4.6 Article

Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia

期刊

CELL CYCLE
卷 19, 期 12, 页码 1454-1465

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2020.1750814

关键词

Urothelial carcinoma-associated 1; miR-296-3p; Myc; acute myeloid leukemia

资金

  1. Key Project of Anhui Provincial Department of Education [KJ2019A0358]
  2. Key Project of Translational Medicine in Bengbu Medical College [BYTM2019034]
  3. Key Project of natural sciences in Bengbu Medical College [BYKY1743ZD]
  4. Science and Technology Development Fund Project of the First Affiliated Hospital of Bengbu Medical College [BYYFYKJ2018013]

向作者/读者索取更多资源

Acute myeloid leukemia (AML) is a common hematopoietic malignancy with a generally poor prognosis. Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been identified as an oncogene in various malignancies including AML. However, the role and mechanisms of UCA1 in AML tumorigenesis were incompletely understood. Hence, this study aims to investigate whether UCA1 regulates AML progression by miR-296-3p/Myc axis. Cell proliferation and apoptosis were evaluated by MTT assay and flow cytometry, respectively. Luciferase reporter assay was performed to analyze the interaction between miR-296-3p and UCA1 or Myc. The results showed that UCA1 knockdown inhibited proliferation and induced apoptosis in AML cells (U937 and HL60). Mechanistically, UCA1 acted as a sponge of miR-296-3p by binding to miR-296-3p. Myc, a target of miR-296-3p, was positively regulated by UCA1. Functional assay showed that the anti-AML effect of UCA1 knockdown could be abrogated by miR-296-3p inhibition and Myc overexpression. Moreover, UCA1 knockdown inhibited AML cell tumorigenesisin vivo, which was associated with regulation of miR-296-3p and Myc expression. In conclusion, UCA1 modulates AML progression by regulating miR-296-3p/Myc axis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据